XENPOZYME

Google image searchProduct monograph

Active ingredient

olipudase alfa, 20 MG/VIAL

DIN: 02545721

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE-USE VIAL

Schedule: Prescription / Schedule D

Company: SANOFI-AVENTIS CANADA INC

Date: 18-OCT-2024

ATC:

• A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD, )
• A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD)
• A16AB — Enzymes (ATC, ATC/DDD)
• A16AB25 — OLIPUDASE ALFA (ATC/DDD)

Pharmaceutical standard: MFR

External Links for Xenpozyme

Search on Google

• Xenpozyme side effects
• Xenpozyme dosage
• olipudase alfa side effects
• olipudase alfa dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find xenpozyme photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.